PANACEA BIOTEC
Back to Income Statement
|
PANACEA BIOTEC Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-8.37 Cr | ₹-1.17 Cr | ₹-33 Cr | ₹1,078 Cr | ₹-148 Cr |
What is the latest Consolidated Net Profit of PANACEA BIOTEC ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹-8.37 Cr |
| Mar2024 | ₹-1.17 Cr |
| Mar2023 | ₹-33 Cr |
| Mar2022 | ₹1,078 Cr |
| Mar2021 | ₹-148 Cr |
How is Consolidated Net Profit of PANACEA BIOTEC Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-8.37 Cr | Negative | |
| Mar2024 | ₹-1.17 Cr | Negative | |
| Mar2023 | ₹-33 Cr | Negative | |
| Mar2022 | ₹1,078 Cr | Positive | |
| Mar2021 | ₹-148 Cr | - | |
Compare Consolidated Net Profit of peers of PANACEA BIOTEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PANACEA BIOTEC | ₹2,440.4 Cr | -3.9% | -4% | -1.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
PANACEA BIOTEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | -3.9% |
-4% |
-1.4% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses